Hot Stocks
Monday, September 19, 2016
UPDATE 2-Sarepta's keenly watched muscle dystrophy drug wins FDA approval
Sept 19 (Reuters) - Sarepta Therapeutics Inc's
Duchenne muscular dystrophy drug won approval from the U.S. Food
and Drug Administration on Monday, capping months of regulatory
uncertainty and...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment